- Trials with a EudraCT protocol (8)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (6)
8 result(s) found for: Endometritis.
Displaying page 1 of 1.
EudraCT Number: 2019-000585-38 | Sponsor Protocol Number: SQ411218 | Start Date*: 2019-08-20 |
Sponsor Name:University Hospitals Coventry and Warwickshire NHS Trust | ||
Full Title: Chronic Endometritis and Recurrent Miscarriage - The CERM trial | ||
Medical condition: Chronic Endometritis and Recurrent Miscarriage | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2009-011775-78 | Sponsor Protocol Number: 08GINE1 | Start Date*: 2009-01-20 |
Sponsor Name:UNIVERSITA` CAMPUS BIOMEDICO | ||
Full Title: Evaluation of efficacy of antibiotic prophylaxis in patients undergoing operative hysteroscopy | ||
Medical condition: Patients needing operative hysteroscopy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: IT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2010-019809-42 | Sponsor Protocol Number: FARM84KPTK | Start Date*: 2010-07-22 | |||||||||||
Sponsor Name:UNIVERSITA` DEGLI STUDI DI NAPOLI FEDERICO II | |||||||||||||
Full Title: Efficacy of methylergometrine daily administration in puerperium | |||||||||||||
Medical condition: Healthy women immediately after a spontaneous delivery | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-000872-89 | Sponsor Protocol Number: MK001 | Start Date*: 2015-10-29 |
Sponsor Name:University of Oxford | ||
Full Title: ANODE: a randomised controlled trial of prophylactic ANtibiotics to investigate the prevention of infection following Operative vaginal DElivery. | ||
Medical condition: Maternal infection in the first six weeks after operative vaginal delivery. | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-002068-29 | Sponsor Protocol Number: 1-09-09-2012 | Start Date*: 2012-12-03 |
Sponsor Name:Jan Stener Joergensen | ||
Full Title: Antibiotic Prophylaxis and Intervention for Postpartum Infections following Caesarean Section | ||
Medical condition: Sub-study 1: women delivering a child by caesarean section Sub-study 2: Women, who are hospitalized at the obstetrical ward for reoperation because of superficial or deep infection or haematoma... | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: DK (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-004482-14 | Sponsor Protocol Number: P160917 | Start Date*: 2019-08-14 |
Sponsor Name:ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS (AP-HP) | ||
Full Title: Tocolysis in the management of preterm premature rupture of membranes before 34 weeks of gestation: a double-blinded randomized controlled trial | ||
Medical condition: Pregnant women with PPROM at 22 to 33 weeks gestation | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: FR (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2016-005113-50 | Sponsor Protocol Number: MVT-601-3002 | Start Date*: 2017-05-22 | ||||||||||||||||
Sponsor Name:Myovant Sciences GmbH | ||||||||||||||||||
Full Title: LIBERTY 2: An International Phase 3 Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study to Evaluate Relugolix Co Administered with and without Low-Dose Estradiol and Norethindron... | ||||||||||||||||||
Medical condition: heavy menstrual bleeding associated with uterine fibroids | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: HU (Completed) CZ (Completed) BE (Completed) PL (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2016-003727-27 | Sponsor Protocol Number: MVT-601-3001 | Start Date*: 2017-06-12 | ||||||||||||||||
Sponsor Name:Myovant Sciences GmbH c/o Vischer AG | ||||||||||||||||||
Full Title: LIBERTY 1: An International Phase 3 Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study to Evaluate Relugolix Co Administered with and without Low-Dose Estradiol and Norethindron... | ||||||||||||||||||
Medical condition: heavy menstrual bleeding associated with uterine fibroids | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: GB (Completed) DE (Completed) PL (Completed) IT (Completed) | ||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
